Last update 01 Nov 2024

B-901

Overview

Basic Info

Drug Type
Bispecific antibody
Synonyms
+ [1]
Target
CD40 x PDL1
Mechanism
CD40 agonists(Tumor necrosis factor receptor superfamily member 5 agonists), PDL1 inhibitors(Programmed death-ligand 1 inhibitors), ADCC(Antibody-dependent cell-mediated cytotoxicity (ADCC) effects)
+ [1]
Therapeutic Areas
Neoplasms
Active Indication
Advanced Malignant Solid NeoplasmSolid tumor
Inactive Indication-
Originator Organization
FutureGen Biopharmaceutical (Beijing) Co., LtdFutureGen Biopharmaceutical (Beijing) Co., LtdStartup
Active Organization
FutureGen Biopharmaceutical (Beijing) Co., LtdFutureGen Biopharmaceutical (Beijing) Co., LtdStartup
Inactive Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with B-901
CTR20231800 / Not yet recruitingPhase 1
评价B901注射液在晚期实体瘤患者中的安全性、耐受性、药代动力学特征和初步疗效的开放性、多中心Ⅰ期临床试验
[Translation] An open-label, multicenter Phase I clinical trial to evaluate the safety, tolerability, pharmacokinetic characteristics and preliminary efficacy of B901 injection in patients with advanced solid tumors
100 Clinical Results associated with B-901
Login to view more data
100 Translational Medicine associated with B-901
Login to view more data
100 Patents (Medical) associated with B-901
Login to view more data
100 Deals associated with B-901
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Advanced Malignant Solid NeoplasmPhase 1
CN
FutureGen Biopharmaceutical (Beijing) Co., LtdFutureGen Biopharmaceutical (Beijing) Co., LtdStartup
19 Jun 2023
Solid tumorIND Approval
US
FutureGen Biopharmaceutical (Beijing) Co., LtdFutureGen Biopharmaceutical (Beijing) Co., LtdStartup
21 Feb 2023
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free